VIVIMED LABS LIMITED (VIVIMEDLAB) financials — quarterly results, P&L, cash flow, balance sheet, shareholding

Vivimed Labs Ltd, established in 1988, is primarily engaged in the Business of Active Pharmaceuticals Ingredients, CDMO Finished Dosage Formulation, Specialty Chemicals and Retail Branded Formulation manufacturing.[1][2]

VIVIMEDLABUpdated 5 Sept 2026, 23:11

Vivimed Labs Limited

Market Cap

₹54.6Cr.

Current Price

₹6.58

High / Low

₹29.4/4.75

ROE%
ROCE-47.3%
Book Value₹-13.5
Face Value₹2.00
Dividend Yield0.00%

About

Vivimed Labs Ltd, established in 1988, is primarily engaged in the Business of Active Pharmaceuticals Ingredients, CDMO Finished Dosage Formulation, Specialty Chemicals and Retail Branded Formulation manufacturing.[1][2]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Mar 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios
CategoryMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days194264144234148118133106104159161284
Inventory Days4107445791,2361,28464095460810634035456
Days Payable84689299160751249577211211266
Cash Conversion Cycle5209406321,3711,27168396361913428930473
Working Capital Days132291168345375319213116-299-311-513-1,828
ROCE %8%7%22%6%6%3%2%-3%-44%-9%-6%-47%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 5 September 2026 at 23:11


Designed & Shipped by Harshit Bansal